Philip W. Kantoff
- Pulmonary and Respiratory Medicine top 0.01%
- Prostate Cancer Treatment and Research 406
- Prostate Cancer Diagnosis and Treatment 173
- Cancer Research top 0.05%
- Cancer, Lipids, and Metabolism 93
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers 38
- Biomaterials top 0.1%
- Immunology top 0.2%
- Immunotherapy and Immune Responses 31
-
- Hormonal and reproductive studies 77
-
- Radiopharmaceutical Chemistry and Applications 61
-
- Sexual Differentiation and Disorders 36
- Co-authors
- Omid C. FarokhzadJinjun ShiRichard WoosterEric J. SmallWilliam OhCelestia S. HiganoAnthony V. D’AmicoDavid F. Penson
- Journals
- Science (3 papers)New England Journal of Medicine (5 papers)Proceedings of the National Academy of Sciences (13 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Philip W. Kantoff
599 papers receiving 47.1k citations
Hit Papers
Peers
Comparison fields: 5 of 191
- Pulmonary and Respiratory Medicine 22.8k
- Cancer Research 8.3k
- Oncology 12.3k
- Biomaterials 4.1k
- Immunology 5.8k
Countries citing papers authored by Philip W. Kantoff
This map shows the geographic impact of Philip W. Kantoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip W. Kantoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip W. Kantoff more than expected).
Fields of papers citing papers by Philip W. Kantoff
This network shows the impact of papers produced by Philip W. Kantoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip W. Kantoff. The network helps show where Philip W. Kantoff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philip W. Kantoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 17 | |
| 2 | 2021 | 24 | |
| 3 | 2020 | 119 | |
| 4 | 2020 | 7 | |
| 5 | 2020 | 17 | |
| 6 | 2019 | 183 | |
| 7 | 2017 | 31 | |
| 8 | 2016 | 73 | |
| 9 | 2016 | 28 | |
| 10 | 2015 | 101 | |
| 11 | 2014 | 139 | |
| 12 | 2014 | 44 | |
| 13 | 2013 | 14 | |
| 14 | 2011 | 24 | |
| 15 | 2010 | 58 | |
| 16 | 2009 | 42 | |
| 17 | 2007 | 371 | |
| 18 | 2007 | 235 | |
| 19 | 2006 | 20 | |
| 20 | 2005 | 121 |
About Philip W. Kantoff
Philip W. Kantoff is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 619 papers that have together received 48.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (406 papers), Prostate Cancer Diagnosis and Treatment (173 papers), Cancer, Lipids, and Metabolism (93 papers), Hormonal and reproductive studies (77 papers), Radiopharmaceutical Chemistry and Applications (61 papers), Cancer Immunotherapy and Biomarkers (38 papers), Sexual Differentiation and Disorders (36 papers) and Immunotherapy and Immune Responses (31 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (22.8k citations), Cancer Research (8.3k citations) and Oncology (12.3k citations). Philip W. Kantoff has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Omid C. Farokhzad, Jinjun Shi, Richard Wooster, Eric J. Small, William Oh, Celestia S. Higano, Anthony V. D’Amico, David F. Penson, Susan Halabi and Robert Dreicer. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.